Mean (SD) age (years) | 44.3 (17.8) | 45.19 (17.3) | 43.12 (18.5) | 0.15* |
Any formal education, n (%) | 505/620 (81.45) | 313/365 (85.75) | 192/255 (75.29) | 0.001 |
Potable water available within the household, n (%) | 246/606 (40.59) | 157/357 (43.98) | 89/249 (35.74) | 0.04 |
Median (IQR) distance to nearest health centre (metres) | 691.81 (436.94–1012.05) | 686.93 (437.35–980.23) | 705.47 (430.94–1211.67) | 0.24† |
Used alcohol, n (%) | 285 (45.97) | 255/365 (69.86) | 30/255 (11.76) | <0.001 |
Used tobacco, n (%) | 169/620 (27.26) | 150/365 (41.10) | 19/255 (7.45) | <0.001 |
Used illegal drug, n (%) | 43/620 (6.94) | 42/365 (11.51) | 1/255 (0.39) | <0.001 |
Homelessness or residence in shelters, n (%) | 23/619 (3.72) | 22/364 (6.04) | 1/255 (0.39) | <0.001 |
Previous imprisonment, n (%) | 168/619 (27.14) | 161/365 (44.11) | 7/254 (2.76) | <0.001 |
HIV infection, n (%) | 15/601 (2.50) | 10/352 (2.84) | 5/249 (2.01) | 0.52 |
Weight loss, n (%) | 522/611 (85.43) | 319/361 (88.37) | 203/250 (81.20) | 0.01 |
Haemoptysis, n (%) | 205/619 (33.12) | 140/364 (38.46) | 65/255 (25.49) | 0.001 |
Cavities on chest radiograph, n (%) | 174/521 (33.40) | 98/298 (32.89) | 76/223 (34.08) | 0.77 |
Infiltrates on chest radiograph, n (%) | 358/531 (67.42) | 230/305 (75.41) | 128/226 (56.64) | <0.001 |
Clustered genotype pattern‡ | 155/623 (24.88) | 87/367 (23.71) | 68/256 (26.56) | 0.42 |
Median (IQR) interval between initiation of symptoms and diagnosis (months) | 2.87 (1.70–5.47) | 2.90 (1.70–5.57) | 2.78 (1.63–5.0) | 0.46† |
Median (IQR) interval between initiation of symptoms and treatment (months) | 3.37 (2.07–5.97) | 3.50 (2.10–6.20) | 3.25 (2.02–5.40) | 0.18† |
Median (IQR) interval between diagnosis and initiation of treatment (months) | 0.20 (0.07–0.43) | 0.20 (0.07–0.047) | 0.02 (0.07–0.37) | 0.22† |
M tuberculosis resistant to isoniazid and rifampin, n (%) | 36/618 (5.83) | 19/366 (5.19) | 17/252 (6.75) | 0.42 |
Initiation of treatment <10 days after diagnosis, n (%) | 408/576 (70.83) | 242/346 (69.94) | 166/230 (72.17) | 0.56 |
Directly supervised treatment, n (%) | 551/562 (98.04) | 333/339 (98.23) | 218/223 (97.76) | 0.69 |
Treatment outcome, n (%) | | | | |
Cure | 471/568 (82.92) | 273/343 (79.59) | 198/225 (88.0) | 0.009 |
Default | 52/568 (9.15) | 41/343 (11.95) | 11/225 (4.89) | 0.002 |
Retreatment during follow up | 47/606 (7.10) | 36/355 (9.30) | 10/251 (3.98) | 0.01 |
Mean (SD) follow up (months) | 40.81 (32.43) | 48.33 (33.43) | 49.48 (30.98) | 0.66* |
Death from TB, n (%) | 52/623 (8.35) | 37/367 (10.08) | 15/256 (5.86) | 0.06 |